Malaria (Plasmodium Falciparum) Clinical Trials
3 recruiting trials for Malaria (Plasmodium Falciparum). Eligibility criteria explained in plain English.
TrialFinderData lists 3 Malaria (Plasmodium Falciparum) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 2 (3 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by Sanaria Inc. (1), Victoria Biomedical Research Institute (1), University of Oxford (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Genetically attenuated PfSPZ Vaccine (biological, 1 trial), followed by Normal Saline (0.9% Sodium Chloride), Artemether lumefantrine tablets.
Track Malaria (Plasmodium Falciparum) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults
This is a phase 2 clinical trial of a Plasmodium falciparum (Pf) late liver stage-arresting replication-competent (LARC) sporozoite (SPZ) vaccine (Sanaria® PfSPZ-LARC2 Vaccine)...
Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated Malaria
This study is investigating an innovative approach to treating uncomplicated malaria by adding a drug called Imatinib to the current standard of care, Artemether + Lumefantrine...
Dose Finding Trial of R21/Matrix-M in School Children
This trial is a double-blind, randomised, trial recruiting participants from the R21 phase IIb trial (VAC 076) which took place between May 2019 and July 2023 in Nanoro, Burkina...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Malaria (Plasmodium Falciparum), with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Malaria (Plasmodium Falciparum), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Malaria (Plasmodium Falciparum), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.